Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;29(7):599-603.
doi: 10.1111/jopr.13220. Epub 2020 Jul 24.

Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses

Avinash S Bidra  1 , Jesse S Pelletier  2 , Jonna B Westover  3 , Samantha Frank  4 , Seth M Brown  4   5 , Belachew Tessema  4   5
Affiliations

Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses

Avinash S Bidra et al. J Prosthodont. 2020 Aug.

Abstract

Purpose: To evaluate the in vitro inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with hydrogen peroxide (H2 O2 ) and povidone-iodine (PVP-I) oral antiseptic rinses at clinically recommended concentrations and contact times.

Materials and methods: SARS-CoV-2, USA-WA1/2020 strain virus stock was prepared prior to testing by growing in Vero 76 cells. The culture media for prepared virus stock was minimum essential medium (MEM) with 2% fetal bovine serum (FBS) and 50 µg/mL gentamicin. Test compounds consisting of PVP-I oral rinse solutions and H2 O2 aqueous solutions were mixed directly with the virus solution so that the final concentration was 50% of the test compound and 50% of the virus solution. Thus PVP-I was tested at concentrations of 0.5%, 1.25%, and 1.5%, and H2 O2 was tested at 3% and 1.5% concentrations to represent clinically recommended concentrations. Ethanol and water were evaluated in parallel as standard positive and negative controls. All samples were tested at contact periods of 15 seconds and 30 seconds. Surviving virus from each sample was then quantified by standard end-point dilution assay and the log reduction value of each compound compared to the negative control was calculated.

Results: After the 15-second and 30-second contact times, PVP-I oral antiseptic rinse at all 3 concentrations of 0.5%, 1.25%, and 1.5% completely inactivated SARS-CoV-2. The H2 O2 solutions at concentrations of 1.5% and 3.0% showed minimal viricidal activity after 15 seconds and 30 seconds of contact time.

Conclusions: SARS-CoV-2 virus was completely inactivated by PVP-I oral antiseptic rinse in vitro, at the lowest concentration of 0.5 % and at the lowest contact time of 15 seconds. Hydrogen peroxide at the recommended oral rinse concentrations of 1.5% and 3.0% was minimally effective as a viricidal agent after contact times as long as 30 seconds. Therefore, preprocedural rinsing with diluted PVP-I in the range of 0.5% to 1.5% may be preferred over hydrogen peroxide during the COVID-19 pandemic.

Keywords: Corona virus; SARS-CoV-2; dental safety; hydrogen peroxide; oral rinse; povidone-iodine.

PubMed Disclaimer

References

    1. Volgenant CMC, Persoon IF, de Ruijter RAG, et al: Infection control in dental health care during and after the SARS‐CoV‐2 outbreak. Oral Dis 2020. In press Accessed May 11, 10.1111/odi.13408 - DOI - PMC - PubMed
    1. Peng X, Xu X, Li Y, et al: Transmission routes of 2019‐nCoV and controls in dental practice. Int J Oral Sci 2020;12:9 - PMC - PubMed
    1. Carrouel F, Conte MP, Fisher J, Gonçalves LS, et al: COVID‐19: a recommendation to examine the effect of mouthrinses with β‐Cyclodextrin combined with citrox in preventing infection and progression. J Clin Med 2020;15:9:1126 - PMC - PubMed
    1. Zou L, Ruan F, Huang M, et al: SARS‐CoV‐2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020;382:1177‐1179 - PMC - PubMed
    1. Harrel SK, Molinari J: Aerosols and splatter in dentistry: a brief review of the literature and infection control implications. J Am Dent Assoc 2004;135:429‐437 - PMC - PubMed